The impact of neoadjuvant therapy vs. upfront surgery on margin-negative resection rate and overall survival among intrahepatic cholangiocarcinoma patients. (March 2019) - Azab, B.; Macedo, F.I.; Ripat, C.; Hoefer, R.; Guye, M.; Livingstone, A.S.; Yakoub, D.